March 28, 2024


For NovoCure Ltd [NVCR], Analyst sees a rise to $15. What next?

NovoCure Ltd [NASDAQ: NVCR] surged by $1.57 during the normal trading session on while it closed the day at $14.64. The company report on March 27, 2024 at 7:00 AM that METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in